SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-037213
Filing Date
2024-03-27
Accepted
2024-03-27 16:20:09
Documents
1
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3887
  Complete submission text file 0000950170-24-037213.txt   5348
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1226 CHARTER LANE AMBLER PA 19002
Business Address
Thorell Marella (Reporting) CIK: 0001826323 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 24790894